The arguments for an early cystectomy in patients with urothelial carcinoma.
作者信息
Barski Dimitri
机构信息
Department of Urology, Lukas Hospital Neuss, Germany.
出版信息
Cent European J Urol. 2014;67(4):333-4. doi: 10.5173/ceju.2014.04.art3.
Abstract
摘要
相似文献
1
The arguments for an early cystectomy in patients with urothelial carcinoma.
Cent European J Urol. 2014;67(4):333-4. doi: 10.5173/ceju.2014.04.art3.
2
The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
J Urol. 2012 Aug;188(2):405-9. doi: 10.1016/j.juro.2012.04.020. Epub 2012 Jun 14.
3
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
J Urol. 2009 Jul;182(1):78-84; discussion 84. doi: 10.1016/j.juro.2009.02.125. Epub 2009 May 17.
4
Fine needle aspiration of urethral recurrence of urothelial carcinoma after radical cystectomy presenting as a perineal mass: a case report.
Acta Cytol. 2008 Jan-Feb;52(1):94-8. doi: 10.1159/000325442.
5
[Surgical treatment of metastatic urothelial carcinoma of the bladder: Review of the Cancer Committee of the French Association of Urology].
Prog Urol. 2013 Oct;23(12):951-7. doi: 10.1016/j.purol.2013.03.004. Epub 2013 Apr 17.
6
The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer?
J Urol. 2013 Nov;190(5):1692-6. doi: 10.1016/j.juro.2013.05.040. Epub 2013 May 23.
7
Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer.
Urology. 2019 Nov;133:157-163. doi: 10.1016/j.urology.2019.07.034. Epub 2019 Aug 14.
8
Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis.
J Urol. 2013 May;189(5):1670-5. doi: 10.1016/j.juro.2012.11.006. Epub 2012 Nov 6.
9
Effect of variant histology presence and squamous differentiation on oncological results and patient's survival after radical cystectomy.
Arch Ital Urol Androl. 2018 Sep 30;90(3):172-175. doi: 10.4081/aiua.2018.3.172.
10
Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder.
Asian J Surg. 2014 Oct;37(4):184-9. doi: 10.1016/j.asjsur.2014.01.010. Epub 2014 Mar 14.
引用本文的文献
1
Survival by T Stage for Patients with Localized Bladder Cancer: Implications for Future Screening Trials.
Bladder Cancer. 2021 Mar 19;7(1):23-31. doi: 10.3233/BLC-200381. eCollection 2021.
2
Outcomes and complications of Hyperthermic IntraVesical Chemotherapy using mitomycin C or epirubicin for patients with non-muscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure.
Cent European J Urol. 2020;73(3):287-294. doi: 10.5173/ceju.2020.0148. Epub 2020 Aug 6.
3
AUTHOR'S REPLY.
Cent European J Urol. 2015;68(2):147. doi: 10.5173/ceju.2015.r101.
本文引用的文献
1
The time from diagnosis of bladder cancer to radical cystectomy in Polish urological centres - results of CysTiming Poland study.
Cent European J Urol. 2014;67(4):329-32. doi: 10.5173/ceju.2014.04.art2. Epub 2014 Dec 5.
2
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.
Eur Urol. 2014 Apr;65(4):778-92. doi: 10.1016/j.eururo.2013.11.046. Epub 2013 Dec 12.
3
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Eur Urol. 2013 Oct;64(4):639-53. doi: 10.1016/j.eururo.2013.06.003. Epub 2013 Jun 12.
4
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.
Eur Urol. 2013 Jan;63(1):45-57. doi: 10.1016/j.eururo.2012.08.009. Epub 2012 Aug 14.
5
Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review.
Eur Urol. 2011 Sep;60(3):493-500. doi: 10.1016/j.eururo.2011.05.045. Epub 2011 Jun 1.
6
The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables.
Eur Urol. 2011 Sep;60(3):423-30. doi: 10.1016/j.eururo.2011.05.033. Epub 2011 May 25.
7
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
Eur Urol. 2010 Feb;57(2):300-9. doi: 10.1016/j.eururo.2009.09.024. Epub 2009 Sep 12.
8
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer.
J Urol. 2007 Apr;177(4):1283-6; discussion 1286. doi: 10.1016/j.juro.2006.11.090.
9
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.
Eur Urol. 2007 Jan;51(1):137-49; discussion 149-51. doi: 10.1016/j.eururo.2006.05.021. Epub 2006 Jun 8.
Zotero 插件